Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Jun;65(6):878-88.
doi: 10.1053/j.ajkd.2015.01.008. Epub 2015 Mar 19.

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort

Affiliations
Observational Study

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort

Bradley A Warady et al. Am J Kidney Dis. 2015 Jun.

Abstract

Background: Few studies have prospectively evaluated the progression of chronic kidney disease (CKD) in children and adolescents, as well as factors associated with progression.

Study design: Prospective multicenter observational cohort study.

Setting & participants: 496 children and adolescents with CKD enrolled in the Chronic Kidney Disease in Children (CKiD) Study.

Predictors: Proteinuria, hypoalbuminemia, blood pressure, dyslipidemia, and anemia.

Outcomes: Parametric failure-time models were used to characterize adjusted associations between baseline levels and changes in predictors and time to a composite event of renal replacement therapy or 50% decline in glomerular filtration rate (GFR).

Results: 398 patients had nonglomerular disease and 98 had glomerular disease; of these, 29% and 41%, respectively, progressed to the composite event after median follow-ups of 5.2 and 3.7 years, respectively. Demographic and clinical characteristics and outcomes differed substantially according to the underlying diagnosis; hence, risk factors for progression were assessed in stratified analyses, and formal interactions by diagnosis were performed. Among patients with nonglomerular disease and after adjusting for baseline GFR, times to the composite event were significantly shorter with urinary protein-creatinine ratio > 2mg/mg, hypoalbuminemia, elevated blood pressure, dyslipidemia, male sex, and anemia, by 79%, 69%, 38%, 40%, 38%, and 45%, respectively. Among patients with glomerular disease, urinary protein-creatinine ratio >2mg/mg, hypoalbuminemia, and elevated blood pressure were associated with significantly reduced times to the composite event by 94%, 71%, and 67%, respectively. Variables expressing change in patient clinical status over the initial year of the study contributed significantly to the model, which was cross-validated internally.

Limitations: Small number of events in glomerular patients and use of internal cross-validation.

Conclusions: Characterization and modeling of risk factors for CKD progression can be used to predict the extent to which these factors, either alone or in combination, would shorten the time to renal replacement therapy or 50% decline in GFR in children with CKD.

Keywords: Chronic Kidney Disease in Children (CKiD) Study; Pediatric; adolescents; children; chronic kidney disease (CKD); disease progression; disease trajectory; end-stage renal disease (ESRD); glomerular filtration rate (GFR); proteinuria; renal replacement therapy (RRT); risk factor; urinary protein-creatinine ratio (UPCR).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier and lognormal survival curves for composite event (50% GFR decline or renal replacement therapy) of baseline urine protein/creatinine for glomerular and non-glomerular subjects.
Figure 2
Figure 2
Kaplan Meier curves showing the predicted standardized times of the composite event resulting from the cross-validation. The expected lognormal survival curve, which is overlaid on top of the predicted survival function, is entirely encompassed inside the 95% confidence intervals of the prediction for both glomerular and non-glomerular children.
Figure 3
Figure 3
Estimates of survival curves for composite event (50% GFR decline or renal replacement therapy) based on lognormal models of children with different constellations of clinical variables for glomerular and non-glomerular subjects. Values of variables in the models not listed in the figure are considered not present (i.e., zero).

References

    1. U.S. Renal Data System. National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD: 2013. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health.
    1. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3–5 in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013;62:245–252. - PMC - PubMed
    1. Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatric nephrology (Berlin, Germany) 2007;22:1999–2009. - PMC - PubMed
    1. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatric nephrology (Berlin, Germany) 2012;27:363–373. - PMC - PubMed
    1. McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. The New England journal of medicine. 2004;350:2654–2662. - PubMed

Publication types

MeSH terms